Discarded Drug Selegiline May Prevent Parkinson's

Parkinson's disease, especially in early stage, may no longer trouble people in the future thanks to the new research of an inexpensive but rarely used drug - Selegiline - one from a group of drugs called monoamine oxidase type B inhibitors (MAOBIs). Researchers looked at 17 trials involving which are used to slow the progression of Parkinson's.

Back to news